GENEDX HOLDINGS (WGS)
(Delayed Data from NSDQ)
$121.37 USD
-0.67 (-0.55%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $122.25 +0.88 (0.73%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth C Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, GeneDx Holdings Corp. has a market cap of $3.51B, which represents its share price of $122.04 multiplied by its outstanding shares number of 28.73M. As a mid-cap company, WGS's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
WGS 121.37 -0.67(-0.55%)
Will WGS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for WGS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WGS
Here's Why Ensign Group Shares Are Attracting Investors Now
Here's Why Pediatrix Medical Shares Are Attracting Investors Now
WGS: What are Zacks experts saying now?
Zacks Private Portfolio Services
PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down
Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up
Other News for WGS
Is WGS set to breakout? NR7 shows up after sliding 1.54%
NR7 appears for WGS after 1.54% move
20 Day Moving Average Resistance appears for WGS after 2.19% move
Piper Sandler Raises Price Target for GeneDx Holdings (WGS) to $140 | WGS Stock News
WGS Fell Below 20 Day Moving Average on September 10